Ratings by Oppenheimer
| Date | Analyst | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|---|
| 10/20/2026 | Jay Olson | Eupraxia Pharmaceuticals | EPRX | Maintain | Outperform (N/A) |
17.00 (N/A) |
|
Details | |
| 10/20/2026 | Brian Schwartz | Braze Inc | BRZE | Downgrade | Perform (Outperform) |
N/A (N/A) |
30.04 (45.57) |
51.7% | Details |
 |
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
| 14,979 more... | |||||||||
